Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) [Phase 2]
Phase 2 clinical trial evaluating Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) with Cemiplimab for locally advanced biliary tract cancer; cu…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Completed clinical trial evaluating frailty scales to predict chemotherapy toxicity in older adults with gastrointestinal cancers.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of trifluridine/tipiracil with oxaliplatin for advanced or metastatic biliary tract cancer…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody [Phase 1, Phase 2]
Clinical trial update for a phase 1/2 study of Candonilimab in combination with LM-302 for Claudin 18.2 positive advanced biliary tract canc…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies [Phase 1]
This clinical trial update describes a Phase 1/1B study of ST-01156, a small-molecule RBM39 degrader, in patients with advanced solid tumors…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
A Phase Ib/II trial evaluating nanoliposomal irinotecan (nal-IRI) in combination with nivolumab as second-line therapy for advanced biliary …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab plus apatinib in combination with GEMOX for locally advanced biliary tract cancer; the…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]
Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
An observational study evaluating first-line systemic therapy combined with celiac plexus blockade for pain in advanced biliary tract cancer…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC [Phase 2]
Phase 2 trial update for SHR-1210 in combination with Apatinib or chemotherapy in advanced hepatocellular carcinoma or biliary tract cancer;…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) [Phase 3]
A Phase 3 study evaluating SHR-8068 plus Adebrelimab and platinum-containing chemotherapy versus Durvalumab plus platinum-containing chemoth…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. [Phase 2]
Phase 2 trial evaluating nivolumab plus relatlimab with gemcitabine/cisplatin as first-line treatment for advanced biliary tract cancer; the…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer [Phase 2]
Phase 2 clinical trial update evaluating nanoliposomal irinotecan with fluorouracil and leucovorin in advanced biliary tract cancer.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) [Phase 2]
Phase 2 clinical trial assessing a four-drug combination (gemcitabine, cisplatin, AB680, AB122) as first-line therapy for advanced biliary t…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating the safety and efficacy of combining regorafenib with durvalumab (MEDI4736) in chemo-refractory advanced bil…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for advanced biliary tract carcinoma. The study has completed.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer [Phase 3]
A Phase 3 clinical trial comparing AK112 plus chemotherapy to Durvalumab plus chemotherapy in advanced biliary tract cancer; the trial is cu…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC [Phase 2]
A Phase 2 trial evaluating adjuvant therapy after surgical resection in biliary tract cancer using a three-drug regimen of capecitabine, len…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment [Phase 2]
Phase 2 clinical trial evaluating lenvatinib plus paclitaxel in patients with advanced biliary tract cancer after gemcitabine-based therapy;…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers [Phase 2]
A Phase II trial is evaluating organoid drug sensitivity testing to guide therapy for unresectable biliary tract cancers, with the study cur…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 [Phase 1]
Phase 1 study assessing adverse events and change in disease activity in adults with select advanced solid tumors treated with ABBV-400; the…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CTX-009 in combination with gemcitabine, cisplatin, and durvalumab as first-line therapy for unresecta…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
An update on the Registry of Genetic Alterations of Taiwan Biliary Tract Cancer, sponsored by the National Health Research Institutes, Taiwa…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Durvalumab (Imfinzi) is studied in a Japan post-marketing surveillance PMS for biliary tract cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
The PERSUASION registry, a prospective German platform for biliary tract cancers including gallbladder carcinoma, has completed its expanded…